Advertisement
Review| Volume 40, ISSUE 6, P887-917, June 01, 1966

The role of antibiotics in the pathogenesis of Candida infections

DOI:https://doi.org/10.1016/0002-9343(66)90204-X
The role of antibiotics in the pathogenesis of Candida infections
Previous ArticleElevation of the serum protein-bound iodine level in inhabitants of the Marshall Islands
Next ArticleFactors affecting the determination of the serum protein-bound iodine
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Kligman A.M.
        Are fungus infections increasing as a result of antibiotic therapy?.
        J.A.M.A. 1952; 149: 979
        • Maibach H.I.
        • Kligman A.M.
        The biology of experimental human cutaneous moniliasis (Candida albicans).
        Arch. Dermat. 1962; 85: 233
        • Merliss R.R.
        • Hoffman A.
        Steatorrhea following the use of antibiotics.
        New England J. Med. 1951; 245: 328
        • Robinson H.M.
        Moniliasis complicating antibiotic therapy.
        Arch. Dermat. & Syph. 1954; 70: 640
        • Baum G.L.
        The significance of candida albicans in human sputum.
        New England J. Med. 1960; 263: 70
        • Kennedy C.B.
        • Henington V.M.
        • Bordelon I.
        • Snider K.
        Monilia (yeast-like) infections of the skin and mucous membrane.
        J. Lab. Med. Soc. 1954; 106: 419
        • Downing J.G.
        • Conant N.F.
        Mycotic infections.
        New England J. Med. 1945; 233: 153
        • Downing J.G.
        • Conant N.F.
        Mycotic infections.
        New England J. Med. 1945; 233: 181
        • Kostmann R.
        Moniliasis of the respiratory tract.
        Acta paediat. 1945; 32: 520
        • Winner H.I.
        • Hurley R.
        Candida Albicans.
        J. & A. Churchill Ltd, London1964 (W.1.)
        • Cross W.G.
        Oral reactions to penicillin.
        Brit. M. J. 1949; 1: 171
        • Geiger A.J.
        • Wenner H.A.
        • Axilrod H.D.
        • Durlacher S.H.
        Mycotic endocarditis and meningitis.
        Yale J. Biol. & Med. 1946; 18: 259
        • Wessler S.
        • Browne H.R.
        Candida albicans (monilia albicans) infection with blood stream invasion; report of a case with a strain clinically resistant to sulfonamide drugs and to penicillin in vitro.
        Ann. Int. Med. 1945; 22: 886
        • Campbell C.C.
        • Saslaw S.
        Enhancement of growth of certain fungi by streptomycin.
        in: Proc. Soc. Exper. Biol. & Med.70. 1949: 562
        • Foley G.E.
        • Winter Jr., W.D.
        Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var. stellatoidea.
        J. Infect. Dis. 1949; 85: 268
        • Zimmerman L.E.
        Candida and aspergillus endocarditis with comments on the role of antibiotics in dissemination of fungus disease.
        Arch. Path. 1950; 50: 591
        • Bazex A.
        Moniliases compliquant les thérapeutiques antibiotiques, leur traitement par la vitamine B12.
        Presse méd. 1951; 59: 1528
        • Bedford P.D.
        Black tongue and oral penicillin.
        Brit. M. J. 1946; 2: 63
        • Behrman H.T.
        Pruritus vulvae due to Aureomycin.
        J.A.M.A. 1950; 144: 995
        • Freeman H.E.
        Robinson-contact dermatitis-silicone putty. Pigmented hairy tongue accompanying antibiotherapy.
        Arch. Dermat. & Syph. 1952; 65: 99
        • Harris H.J.
        Aureomycin and chloramphenicol in brucellosis.
        J.A.M.A. 1950; 142: 161
        • Hewitt W.L.
        • Williams Jr., B.
        Chloromycetin (chloramphenicol) in the treatment of infections.
        New England J. Med. 1950; 242: 119
        • Mangiaracine A.
        Oral moniliasis following antibiotic therapy—a warning.
        New England J. Med. 1951; 244: 655
        • Manheim S.D.
        Anorectal complications of Aureomycin, Terramycin, and Chloromycetin therapy.
        New York J. Med. 1951; 51: 2759
        • McVay Jr., L.V.
        • Sprunt D.H.
        A Study of moniliasis in Aureomycin therapy.
        in: Proc. Soc. Exper. Biol. & Med.78. 1951: 759
        • Meads M.
        • Rowe W.P.
        • Haslam N.M.
        Alterations in the bacterial flora of the throat during oral therapy with Aureomycin.
        Arch. Int. Med. 1951; 87: 533
        • Ormerod F.C.
        • Friedmann I.
        A case of moniliasis.
        Brit. M. J. 1951; 2: 1439
        • Pappenfort Jr., R.B.
        • Schnall E.S.
        Moniliasis in patients treated with Aureomycin.
        Arch. Int. Med. 1951; 88: 729
        • Reiches A.J.
        Antibiotic sensitivity and moniliasis.
        Arch. Dermat. & Syph. 1951; 64: 604
        • Rossier von P.H.
        Antibiotica und Mykosen.
        Helvet med. acta. 1952; 19: 261
        • Williams Jr., B.
        Oral and pharyngeal complications of chloramphenicol (Chloromycetin) therapy.
        Am. Pract. & Digest Treat. 1950; 1: 897
        • Woods J.W.
        • Manning Jr., I.H.
        • Patterson C.N.
        Monilial infections complicating the therapeutic use of antibiotics.
        J.A.M.A. 1951; 145: 207
        • Barach A.L.
        • Bickerman H.A.
        • Beck G.J.
        Antibiotic therapy in infections of the respiratory tract.
        Arch. Int. Med. 1952; 90: 808
        • Moore M.
        In vivo and in vitro effect of Aureomycin hydrochloride on syringospora (Monilia, Candida) albicans.
        J. Lab. & Clin. Med. 1951; 37: 703
        • Smith D.T.
        The disturbance of the normal bacterial ecology by the administration of antibiotics with the development of new clinical syndromes.
        Ann. Int. Med. 1952; 37: 1135
        • Wolff F.W.
        Moniliasis pneumonia following Aureomycin therapy.
        Lancet. 1952; 1: 1237
        • Kunstadter R.H.
        • Maclean H.
        • Greengard J.
        Mycotic endocarditis due to candida albicans.
        J.A.M.A. 1952; 149: 829
        • Wybel R.E.
        Mycosis of cervical spinal cord following intrathecal penicillin therapy.
        Arch. Path. 1952; 53: 167
        • Taylor H.
        • Rundle J.A.
        Acute moniliasis of the urinary tract.
        Lancet. 1952; 1: 1236
        • Gausewitz P.L.
        • Jones F.S.
        • Worley Jr., G.
        Fatal generalized moniliasis.
        Am. J. Clin. Path. 1951; 21: 41
        • Grekin R.H.
        • Cawley E.P.
        • Zheutlin B.
        Generalized aspergillosis.
        Arch. Path. 1950; 49: 387
        • Vanbreuseghem R.
        • Balsacq J.
        • Bertrand
        Moniliase généralisée par Candida albicans chez un' enfant indigene au Congo Belge apres un traitement par les antibiotiques.
        Ann. Soc. belge méd., trop. 1952; 32: 513
        • Lipnik M.J.
        • Kligman A.M.
        • Strauss R.
        Antibiotics and fungous infections.
        J. Invest. Dermat. 1952; 18: 247
        • Munoz J.
        • Geister R.
        Inhibition of phagocytosis by Aureomycin.
        in: Proc. Soc. Exper. Biol. & Med.75. 1950: 367
        • Paine Jr., T.F.
        In vitro experiments with monilia and Escherichia coli to moniliasis in patients receiving antibiotics.
        Antibiotics & Chemother. 1952; 2: 653
        • Seligmann E.
        Virulence enhancing activities of aureornycin on Candida albicans.
        in: Proc. Soc. Exper. Biol. & Med.79. 1952: 481
        • Seligmann E.
        Virulence enhancement of Candida albicans by antibiotics and cortisone.
        in: Proc. Soc. Exper. Biol. & Med.83. 1953: 778
        • Finland M.
        • Weinstein L.
        Complications induced by antimicrobial agents.
        New England J. Med. 1953; 248: 220
        • Hutchison M.K.
        Moniliasis: a complication of antibiotic therapy.
        J. Kansas M. Soc. 1953; 54: 436
        • Wegmann Von T.
        Pilzerkrankuńgen der inneren Organe als Folge von Behandlung mit Anti-biotica, unter besonderer Berücksichtigung des Respirationstraktes. Antibiotica et Chemotherapia, Fortschr. I.
        in: S. Karger, Basel/New York1954: 235
        • Rhoads P.S.
        Hazards of antibiotic therapy.
        Arch. Int. Med. 1952; 90: 731
      52. Editorial. Super-infections during antibiotic treatment.
        Brit. M. J. 1952; 1: 537
      53. Editorial. Moniliasis.
        Lancet. 1952; 1: 1247
      54. Vaginal discharge.
        J.A.M.A. 1954; 156 (Editorial): 991
        • Stormont R.T.
        Council on pharmacy and chemistry. Warning statement to be included in Aureomycin hydrochloride, chloramphenicol and Terramycin hydrochloride, labeling.
        J.A.M.A. 1951; 145: 1267
        • Andriole V.T.
        • Kravetz H.M.
        • Roberts W.C.
        • Utz J.P.
        Candida endocarditis.
        Am. J. Med. 1962; 32: 251
        • Cannon P.R.
        The changing pathologic picture of infection since the introduction of chemotherapy and antibiotics.
        Bull. New York Acad. Med. 1955; 31: 87
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94: 234
        • Debre R.
        • Mozziconacci P.
        • Drouhet E.
        • Drouhet V.
        • Hoppeler A.
        Les infections à Candida chez le nourrisson.
        Ann. paediat. 1955; 184: 129
      60. De Graciansky P. Delaporte J. Accidents a Lévures des Traitements Par Les Antibiotiques. Masson et Cie, Paris1956
        • Drouhet E.
        Antifongiques et therapeutique des mycoses.
        Semaine hôp. Paris. 1957; 33: 843
        • Drouhet E.
        • Vieu M.
        Biologie des infections à Candida. I. Diagnostic de laboratoire. (Étude de 342 souches de: Candida isolées de prélévements pathologiques).
        Semaine hôp. Paris. 1957; 33: 793
        • Drouhet E.
        Biologie des infections à Candida. II. Sur les manifestations pathologiques et les conditions étiologiquès et pathogéniques de 175 cas de candidose.
        Semaine hôp. Paris. 1957; 33: 807
        • Drouhet M.E.
        Quelques aspects mycologiques, pathogéniques et thérapeutiques des candidoses.
        Bull. Soc. franc. dermat. et syph. 1960; 67: 646
        • Lutz A.
        • Grootten O.
        • Witz M.A.
        Étude sur des champignons levuriformes du genre Candida-leur fréquence-l'action de la Mycostatine et de la Trichomycine.
        Rev. d'immunol. 1957; 21: 237
        • Giunchi G.
        Candidosis following antibiotic therapy.
        Sc. med. ital. 1958; 6: 580
        • Kashkin P.N.
        • Krassilnicov N.A.
        • Nekachalov V.Y.
        Candida complications after antibiotic therapy.
        Mycopath. et mycol. appl. 1961; 14: 173
        • Awachat A.K.
        Candidiasis.
        Antiseptic. 1961; 58: 43
        • Donomae I.
        • Kawamori Y.
        Moniliasis.
        J. Antibiotics. 1955; 8 (s. A and B): 171
        • Donomae I.
        Panel discussion on candidiasis.
        J. Antibiotics. 1958; 11 (s.A., supp.:): 62
        • Donomae I.
        • Takahashi H.
        • Tsubura E.I.
        Incidence of candidiasis in Japan deep-seated candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 1
        • Sternberg T.H.
        • Newcomer V.D.
        Therapy of fungus diseases. An international symposium. Little, Brown & Co, Boston1955
        • Keye Jr., J.D.
        • Magee W.E.
        Fungal diseases in a general hospital. A study of 88 patients.
        Am. J. Clin. Path. 1956; 26: 1235
        • Torack R.M.
        Fungus infections associated with antibiotic and steroid therapy.
        Am. J. Med. 1957; 22: 872
        • Baker R.D.
        Leukopenia and therapy in leukemia as factors predisposing to fatal mycoses.
        Am. J. Clin. Path. 1962; 37: 358
        • Gruhn J.G.
        • Sanson J.
        Mycotic infections in leukemic patients at autopsy.
        Cancer. 1963; 16: 61
        • Carpenter A.M.
        Studies on candida. I. Identification of 100 yeast-like fungi isolated from children.
        Am. J. Clin. Path. 1955; 25: 98
        • Gerloczy F.
        • Schmidt K.
        • Scholz M.
        Beiträge zur Frage der Moniliasis im Säuglingsalter.
        Ann. Pediat. 1956; 187: 119
        • Goto T.
        Studies on candidiasis in the oral and the oto-laryngological aspect.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 183
        • Hildick-Smith G.
        • Blank H.
        • Sarkany I.
        Fungus diseases and their treatment.
        J. & A. Churchill Ltd, London1964
        • Dearing W.H.
        • Heilman F.R.
        The effect of Aureomycin on the bacterial flora of the intestinal tract of man: a contribution to preoperative preparation.
        in: Proc. Staff Meet. Mayo Clin.25. 1950: 87
        • Loh W.P.
        • Baker E.E.
        Fecal flora of man after oral administration of chlortetracycline or oxytetracycline.
        Arch. Int. Med. 1955; 95: 74
        • Carter J.J.
        • Covert S.V.
        • Eckert C.
        Nystatin in the control of fungous overgrowth during large bowel chemotherapy.
        Arch. Surg. 1960; 80: 541
        • Cox Jr., R.S.
        • Hannon J.L.
        An evaluation of neomycin plus nystatin as a monilial suppressant in preoperative bowel preparation.
        Antibiotics Ann. 1957–1958; : 658
        • Spaulding E.H.
        • Tyson R.R.
        • Harris M.J.
        • Jacobs B.
        • Wildrick L.
        • Johnson K.O.
        Further studies on intestinal antisepsis: neomycin-nystatin.
        Antibiotics Ann. 1956–1957; : 236
        • Spaulding E.H.
        • Rao N.U.
        • Tyson R.R.
        • Zubrzycki L.
        • Harris M.J.
        Antifungal action of nystatin on, the fecal flora during administration of neomycin-polymyxih.
        Antibiotics Ann. 1955–1956; : 681
        • Meleney F.L.
        • Johnson B.A.
        Alimentary tract antisepsis with oral bacitracin and neomycin.
        Antibiotics Ann. 1956–1957; : 244
        • Reiersol S.
        Occurrence of yeasts in the intestinal tract of 20 patients during treatment with bacitracin and neomycin. Antonie v. Leeuwenhoek.
        J. Microbiol. & Serol. 1958; 24: 23
        • Spaulding E.H.
        • Tyson R.R.
        The role of nystatin in intestinal antisepsis.
        Monogr. Ther. 1957; 2: 38
        • Cohn Jr., I.
        • Longacre A.B.
        Preoperative sterilization of the colon. Comparison of various antibacterial agents.
        in: Welch H. Marti-Ibañez F. Antibiotics Annual, 1955–1956. Medical Encyclopedia, Inc, New York1956: 105
        • Cohn Jr., I.
        • Longacre A.B.
        Preoperative sterilization of the colon. Comparison of various antibacterial agents. II.
        Antibiotics Ann. 1956–1957; : 253
        • Cohn Jr., I.
        • Longacre A.B.
        Preoperative sterilization of the colon. Comparison of various antibacterial agents. IV.
        Antibiotics Ann. 1958–1959; : 761
        • Cohn Jr., I.
        Yeast growth during preoperative preparation of the colon with antibiotics.
        Monogr. Ther. 1957; 2: 43
        • Andreassen M.
        • Eriksen K.R.
        • Stenderup A.
        Monilial peritonitis as a complication of preoperative intestinal sterilisation.
        Lancet. 1958; 2: 618
        • Ishiyama S.
        Nystatin and gastrointestinal candidase.
        J. Antibiotics. 1958; 11 (s.A, supp.:): 17
        • Reynell P.C.
        • Martin E.A.
        • Beard A.W.
        Monilia peritonitis.
        Brit. M. J. 1953; 1: 919
        • Braude A.I.
        • Rock J.A.
        The syndrome of acute disseminated moniliasis in adults.
        Arch. Int. Med. 1959; 104: 91
        • Conn N.K.
        • Crean G.P.
        • Maccabe A.F.
        Systemic candidiasis and endocarditis due to C. tropicalis.
        Brit. M. J. 1959; 1: 944
        • Louria D.B.
        • Dineen P.
        Amphotericin B in treatment of disseminated moniliasis.
        J.A.M.A. 1960; 174: 273
        • Matthias J.Q.
        • Rees E.G.
        Candida septicemia complicating antibiotic therapy.
        J. Path. Bact. 1956; 71: 512
        • Richet G.
        • Drouhet E.
        • Ducrot H.
        • Jungers P.
        Guérison de deux cas de septicémie à Candida albicans compliquant une anurie grave. Action de l'amphotéricine.
        Bull. et mém. Soc. m'ed. hôp. Paris. 1959; 75: 780
        • Vergez J.
        • Simon R.
        Pyonéphrose à “Monilia albicans.”.
        Mém. Acad. Chir. 1953; 79: 422
        • Akiba T.
        • Iwata K.
        • Inoue S.
        Studies on the serologic diagnosis of candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 65
        • McGovern J.J.
        • Parrott R.H.
        • Emmons C.W.
        • Ross S.
        • Burke F.G.
        • Rice E.C.
        The effect of Aureomycin and chloramphenicol on the fungal and bacterial flora of children.
        New England J. Med. 1953; 248: 397
        • Garrahan J.P.
        • Sampayo R.L.
        • Meroni R.J.
        • Landivar R.O.
        • Masanti J.G.
        Accion de los antibioticos y quimioterapicos sobre la incidencia del genero candida en el tracto gastrointestinal. Efectos de la nistatina.
        Res. Asoc. méd. argent. 1957; 71: 27
        • Sharp J.L.
        The growth of Candida albicans during antibiotic therapy.
        Lancet. 1954; 1: 390
        • Newcomer V.D.
        • Wright E.T.
        • Sternberg T.H.
        The effect of nystatin when administered simultaneously with tetracycline upon the yeast flora of the gastrointestinal tract of man.
        Antibiotics Ann. 1954–1955; : 686
        • Sternberg T.H.
        • Tarbet J.E.
        • Newcomer V.D.
        • Huddleson H.G.
        • Weir R.H.
        • Wright E.T.
        • Egeberg R.O.
        Antifungal effects of nystatin on the fecal flora of animals and man.
        Antibiotics Ann. 1953–1954; : 199
        • Bartels H.A.
        Monilial infection of the mouth following antibiotic therapy.
        Oral Surg. 1953; 7: 790
        • Bartels H.A.
        • Buchbinder M.
        Yeastlike microorganisms isolated from root canals.
        Oral Surg. 1954; 7: 98
        • Mountain D.C.
        Oral uudecylinic acid in the prevention of the so-called monilial complications secondary to the use of Aureomycin, Chloramphenicol and Terramycin.
        Am. J. M. Sc. 1953; 225: 274
        • Weinstein L.
        • Goldfield M.
        • Chang T.W.
        Infections occurring during chemotherapy. A study of their frequency, type and predisposing factors.
        New England J. Med. 1954; 251: 247
        • Childs A.J.
        Effect of nystatin on growth of Candida albicans during antibiotic therapy.
        Brit. M. J. 1956; 1: 660
        • Childs A.J.
        Further clinical trials of amphotericin.
        Scottish. M. J. 1959; 4: 80
        • From P.
        • Alli J.H.
        Clinical, bacteriological, and mycological evaluation of tetracyclinenystatin (Mysteclin) in pulmonary disease.
        Antibiotic Med. & Clin. Ther. 1958; 5: 639
        • Fuji R.
        • Ichihashi H.
        • Minamitani M.
        • Morota S.
        • Hoshiyama K.
        • Takiguchi F.
        • Ishibashi T.
        Studies on the Candida infections in childhood.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 40
        • Halde C.
        • Wright E.T.
        • Pollard II, W.H.
        • Newcomer V.D.
        • Sternberg T.H.
        The effect of amphotericin B upon the yeast flora of the gastrointestinal tract of man.
        Antibiotics Ann. 1956–1957; : 123
        • Hewitt W.L.
        • Finegold S.M.
        • Sutter V.L.
        Incidence of side effects and changes in fecal microflora following administration of tetracycline and tetracycline-nystatin.
        Antibiotics Ann. 1955–1956; : 856
        • Kozinn P.J.
        • Burchall J.J.
        • Taschdjian C.L.
        Clinical trial of tetracyclirie-amphotericin B in pediatric patients.
        Squibb Clin. Res. Notes. 1960; 3: 3
        • Kozinn P.J.
        • Burchall J.J.
        • Katz A.
        • Taschdjian C.L.
        Clinical trial of an amphotericin B-tetracycline combination in pediatric patients.
        Antibiotic Med. & Clin. Ther. 1960; 7: 749
        • Larkin R.
        Side-effects of tetracycline alone and of tetracycline with nystatin.
        Lancet. 1959; 1: 1228
        • Lepper M.H.
        • Pearson J.Z.
        A study of the effect of tetracycline plus nystatin on aerobic fecal flora as compared to tetracycline alone.
        Antibiotics Ann. 1956–1957; : 221
        • Metzger W.L.
        • Steigmann F.
        • Jenkins Jr., C.J.
        • Pamukcu S.F.
        • Kaminski L.
        Comparative effects of tetracycline alone and in combination with nystatin on the intestinal flora of man.
        Antibiotics Ann. 1956–1957; : 208
        • Range G.L.
        • Oriatti M.D.
        • Engbring G.M.
        Therapeutic results and changes in fecal flora relative to side effects of tetracycline-nystatin.
        Antibiotics Ann. 1956–1957; : 216
        • Reichelderfer T.E.
        Tetracycline-amphotericin B in pediatric practice, preliminary evaluation.
        Antibiotic Med. & Clin. Ther. 1960; 7: 541
        • Sklar E.M.
        Proliferation of yeast-like fungi during oral antibiotic therapy.
        M. Press. 1961; 245: 227
        • Uchimura R.
        • Nakazawa S.
        • Numao K.
        • Ogawa G.
        Clinical treatment with nystatin.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 32
        • Younger D.
        • Epifano L.D.
        • DiPillo F.
        • Hoffman I.
        • Thaler E.
        • Yarvis M.
        A clinical comparison of the side effects of tetracyclinenystatin and tetracycline.
        Antibiotic Med. & Chemother. 1959; 6: 216
        • Baden W.E.
        Staphylococcal and subsequent Candida albicans enterocolitis complicating novobiocin therapy.
        Am. J. Obst. & Gynec. 1957; 74: 47
        • Blank H.
        Antifungal antibiotics in clinical medicine.
        Arch. Dermat. & Syph. 1957; 75: 184
        • Blank H.
        Candida albicans. Frequent companion, occasional foe.
        Monogr. Ther. 1957; 2: 1
        • Drouhet E.
        Therapeutic activity on nystatin (Mycostatin) in Candida infections.
        in: Sternberg T.H. Newcomer V.D Therapy of Fungus Diseases. An International Symposium. Little, Brown & Co, Boston, Toronto1955: 211
        • Garbulsky M.
        • Yarsky R.
        Niveles plasmaticos de tetraciclina despues de la administracion oral de tres preparados diferentes. Clorhidrato de oxitetraciclina, clorhidrato de tetraciclina y complejo de fosfato de tetraciclina.
        Med. Panamericana. 1960; 14: 283
        • Huang N.N.
        • Sarria A.
        • High R.H.
        Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants and children.
        Antibiotics Ann. 1957–1958; : 59
        • Iacapraro G.
        Una nueva sal de tetraciclina: fosfato de tetraciclina. Estudio preliminar.
        Semana méd. 1958; 112 (Jan. 9): 54
        • Iacapraro G.
        Observaciones clinicas con la asociacion complejb de fosfato de tetraciclina-nistatina.
        Semana méd. 1958; 112: 171-178
        • Kitamura K.
        • Fukushiro R.
        • Kagawa S.
        • Nishiyama S.
        • Takahashi H.
        Black hairy tongue.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 156
        • Koyama Y.
        • Koya G.
        • Kosakai N.
        • Yano N.
        Incidence of Candida contamination in oral cavity among hospital patients and the treatment of upper respiratory candidiasis with nystatin.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 25
        • Kozinn P.J.
        • Taschdjian C.L.
        Oral thrush treated with lyophilized nystatin.
        Antibiotics Ann. 1957–1958; : 75
        • Kozinn P.J.
        • Taschdjian C.L.
        • Dragutsky D.
        • Minsky A.
        Therapy of oral thrush: a comparative evaluation of gentian violet, mycostatin, and amphotericin B.
        Monogr. Ther. 1957; 2: 16
        • Lepper M.H.
        The use of nystatin in the control of candidiasis, particularly that following the use of antibacterial agents.
        Monogr. Ther. 1957; 2: 7
        • Quinn L.Y.
        • Wilbur R.D.
        • Catron D.V.
        In vitro response of Candida albicans and Candida tropicalis to antifungal agents.
        Antibiotics & Chemother. 1960; 10: 95
        • Reichert J.
        Pruritus ani and antibiotics.
        Am. J. Proctol. 1955; 6: 57
        • Robinson M.M.
        Treatment of acne vulgaris with tetracycline-nystatin and tetracycline.
        Antibiotics Ann. 1957–1958; : 451
        • Sappington T.S.
        • McCarten W.G.
        • Clarence L.H.
        Diarrhea and Candida albicans infestation of the colon.
        M. Ann. District of Columbia. 1963; 32: 48
        • Stewart G.T.
        Laboratory and clinical studies with nystatin in post-antibiotic mycotic infections.
        Brit. M. J. 1956; 1: 658
        • Stough A.H.
        • Groel J.T.
        • Kroeger W.H.
        Efficacy of amphotericin in controlling Candida albicans in patients treated with tetracycline.
        Squibb Clin. Res. Notes. 1960; 3: 8
        • Trafton H.M.
        • Lind H.E.
        Use of a combined formulation of tetracycline phosphate complex and amphotericin B in therapy of urinary tract: infections.
        Current Therap. Res. 1961; 3: 59
        • Trafton H.M.
        • Lind H.E.
        Tetracycline phosphate complex and amphotericin B in the treatment of urinary tract infections.
        Antimicrobial Agents Ann. 1960. 1961; : 543
        • Dowling H.F.
        Council on drugs. Mixtures of antibiotics.
        J.A.M.A. 1957; 164: 44
        • Barlow A.J.E.
        Candidiasis.
        Brit. J. Dermat. 1960; 72: 419
        • Drummond M.
        Clinical and therapeutic aspects of Candida albicans.
        Irish J. M. Sc. 1956; 6: 415
        • Kozinn P.J.
        • Taschdjian C.L.
        Enteric candidiasis. Diagnosis and clinical considerations.
        Pediatrics. 1962; 30: 71
        • Lederer H.
        • Todd R.M.
        Thrush in infancy.
        Arch. Dis. Childhood. 1949; 24: 200
        • Brabander J.O.W.
        • Blank F.
        • Butas C.A.
        Intestinal moniliasis in adults.
        J. Canad. M. A. 1957; 77: 478
        • Taschdjian C.L.
        • Kozinn P.J.
        Laboratory and clinical studies on candidiasis in the new-born infant.
        J. Pediat. 1957; 50: 426
        • Kozinn P.J.
        • Taschdjian C.L.
        Oral moniliasis.
        New England J. Med. 1962; 266: 208
        • Beemer A.M.
        • Pryce D.M.
        • Riddell R.W.
        Candida albicans infection of the gut.
        J. Path. & Bact. 1954; 68: 359
        • De Gavaller B.
        Moniliasis en los recien nacidos.
        Res. obstet. y ginec. 1953; 13: 203
        • Lelong M.
        • Alison F.
        • Vinh L.T.
        • Van Ty D.
        • Desmonts G.
        • Cabanes J.
        Le muguet généralisé (septicémie à Candida albicans).
        Ann. méd. 1953; 54: 5
        • Stein A.A.
        Systemic moniliasis: a clinicopathological report of five cases.
        Antibiotic Med. 1959; 6: 297
        • Craig J.M.
        • Farber S.
        The development of disseminated visceral mycosis during therapy for acute leukemia.
        Am. J. Path. 1953; 29: 601
        • Dobias B.
        Treatment of cutaneous moniliasis in pediatrics with nystatin.
        Monogr. Therapy. 1957; 2: 49
        • Harrell E.R.
        • Thompson G.R.
        Systemic candidiasis (moniliasis) complicating treatment of bacterial endocarditis, with review of literature and report of apparent cure of one case with parenteral mycostatin.
        Ann. Int. Med. 1958; 49: 207
        • Louria D.B.
        • Stiff D.P.
        • Bennett B.
        Disseminated moniliasis in the adult.
        Medicine. 1962; 41: 307
        • Vince S.
        The spread of Candida in infants and children.
        M. J. Australia. 1959; 46: 143
        • Vince S.
        Generalized endogenous mycosis in childhood.
        M. J. Australia. 1959; 46: 145
        • Zimmerman L.E.
        Fatal fungus infections complicating other diseases.
        Am. J. Clin. Path. 1955; 25: 46
        • Lee A.F.
        • Keifer W.S.
        Vaginal discharge.
        Northwest Med. 1954; 53: 1227
        • Pace H.R.
        • Schantz S.I.
        The changing incidence of monilial (Candida albicans) vaginitis.
        Monogr. Ther. 1957; 2: 29
        • Carter B.
        • Jones C.P.
        • Creadick R.N.
        • Parker R.T.
        • Turner V.
        The vaginal fungi.
        Ann. New York Acad. Sc. 1959; 83: 265
        • Hesseltine H.C.
        Biologic and clinical import of vulvo-vaginal mycoses.
        Am. J. Obst. & Gynec. 1937; 34: 855
        • Hesseltine H.C.
        Factors relating to mycotic and trichomonal infections.
        Ann. New York Acad. Sc. 1959; 83: 245
        • Plass E.D.
        • Hesseltine H.C.
        • Borts I.H.
        Monilia vulvo-vaginitis.
        Am. J. Obst. & Gynec. 1931; 21: 320
        • Gardner H.L.
        Vaginal thrush.
        Texas State J. Med. 1944; 40: 333
        • Yaffee H.S.
        • Grots I.
        Moniliasis due to norethynodrel with mestranol.
        New England J. Med. 1965; 272: 647
        • Grasset J.
        • Seneze J.
        • Gauthier R.
        Contribution a l'étude des mycoses vulvo-vaginales.
        Bull. féd. soc. gynéc. et obst. 1954; 6: 181
        • Pundel J.P.
        • Ost E.
        Mycoses vulvo-vaginales et antibiotiques.
        Bull. féd. soc, gynéc. & obst. 1954; 6: 170
        • Gaudefroy M.
        • Viart P.
        Influence des antibiotiques sur la recrudescence actuelle des vaginites mycosiques.
        Ann. Biol. Clin. 1955; 13: 113
        • Waisman M.
        Genital moniliasis as a conjugal infection.
        Arch. Dermat. & Syph. 1954; 70: 718
        • Barr CXIII, W.
        Nystatin.
        Practitioner. 1957; 178: 616
        • Notake Y.
        • Taya M.
        • Sasaki H.
        Candidiasis in obstetrics and gynecology.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 9
        • Fujimori H.
        • Takeda H.
        • Tomita T.
        Clinical experience of nystatin for gynecological candidiasis.
        J. Antibiotics. 1958; 11 (S.A. supp.:): 13
        • Mizuno S.
        Vulvo-vaginal candidiasis. Survey of vulvovaginal candidiasis in Japan.
        in: Studies of Candidiasis in Japan. Research Committee of Candidiasis, Japan1961: 19
        • Mizuno S.
        • Yoshimoto S.
        • Nagamine T.
        • Kinoue Y.
        Therapeutic effect of nystatin in vaginal and vulvar candidiasis.
        J. Antibiotics. 1958; 11 (s.A. supp.:): 14
        • Woodruff P.W.
        • Hesseltine H.C.
        Relationship of oral thrush to vaginal mycosis and incidence of each.
        Am. J. Obst. & Gynec. 1938; 36: 467
        • Pace H.R.
        • Schantz S.I.
        The changing incidence of monilial (Candida albicans) vaginitis.
        Monogr. Ther. 1957; 2 (Cited in [170].): 29
        • Bret J.
        • Coupe C.
        Vaginites et infection neonatale. Etiologie des mycoses du nouveauné.
        Presse méd. 1958; 66: 937
        • Kozinn P.J.
        • Taschdjian C.L.
        • Wiener H.
        • Dragutsky D.
        • Minsky A.
        Neonatal candidiasis.
        Pediat. Clin. North America. 1958; 5: 803
        • Swift S.
        Diaper dermatitis.
        Pediat. Clin. North America. 1956; 3: 759
        • Willi H.
        Generalisierte Moniliase der Haut bei einem Neugeborenen.
        Schweiz. med. Wchnschr. 1961; 91: 376
        • Larroche J.-Cl.
        Candidose pulmonaire chez des prematures. Discussion de leur origine foetale.
        Sem. hôp. Paris. 1957; 33: 829
        • Herpay Z.
        Die Lungenmykose Neugeborener.
        Mykosen. 1959; 2: 97
        • Robinson R.C.V.
        Nystatin in the treatment of cutaneous moniliasis.
        Monogr. Ther. 1957; 2: 55
        • Duncan A.G.
        Cutaneous moniliasis.
        Arch. Dermat. 1957; 76: 434
        • Higuchi K.
        • Urabe H.
        • Toshitani S.
        Dermatological candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 12
        • Sulzberger M.B.
        • Baer R.L.
        Some recent advances in dermatologie mycology. Tinea pedis: Trichophyton rubrum infections; Tinea capitis; moniliasis.
        in: Yearbook of Dermatology & Syphilis. 1954–1955. The Yearbook Publishers, Chicago1955: 7
        • Wright E.T.
        • Newcomer V.D.
        • Halde C.
        • Sternberg T.H.
        The use of nystatin for the treatment of candidiasis of the skin and mucous membranes.
        Monogr. Ther. 1957; 2: 12
        • Kubo I.
        • Hori M.
        • Niitani H.
        • Yokoyama I.
        • Takemoto T.
        Studies on the pathogenesis of candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 145
        • Nityanada K.
        Monilial granuloma.
        Brit. M. J. 1959; : 690
        • Robinson R.C.V.
        Cutaneous moniliasis in infants.
        J. Pediat. 1957; 50: 721
        • Bound J.P.
        Thrush napkin rashes.
        Brit. M. J. 1956; 1: 782
        • Hill L.W.
        The treatment of eczema in infants and children. II.
        J. Pediat. 1955; 47: 357
        • Cabaniss Jr., W.H.
        • Manley W.F.
        • Swan R.E.
        Cutaneous moniliasis in a premature infant. Report of a case with unusual clinical manifestations.
        J. Pediat. 1957; 50: 480
        • Mayer J.B.
        • Gotz H.
        • Seitz G.
        Eine Epidemie von Soormykose der Körperhaut unter dem Bilde der Erythrodermia desquamativa (Leiner).
        Ann. Paediat. 1951; 177: 213

      206. (b) Seelig, M. S. Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunologic defenses. Bacteriol. Rev., to be published.

        • Winner H.I.
        A study of Candida albicans agglutinins in human sera.
        J. Hyg. 1955; 53: 509
        • Rimbaud Mm.P.
        • Rioux J.A.
        • Bastide J.M.
        Les phénomènes immunologiques dans les candidoses: les réactions sérologiques.
        Bull. Soc. franç. dermat. & syph. 1960; 67: 673
        • Brody J.I.
        • Finch S.C.
        Candida-reacting antibody in the serum of patients with lymphomas and related disorders.
        Blood. 1960; 15: 830
        • Roth Jr., F.J.
        • Boyd C.C.
        • Sagami S.
        • Blank H.
        An evaluation of the fungistatic activity of serum.
        J. Invest. Dermat. 1959; 32: 549
        • Roth Jr., F.J.
        • Goldstein M.I.
        Inhibition of growth of pathogenic yeasts by human serum.
        J. Invest. Dermat. 1961; 36: 383
        • Louria D.B.
        • Brayton R.G.
        A substance in blood lethal for Candida albicans.
        Nature. 1964; 201: 309
        • Louria D.B.
        • Fallon N.
        • Browne H.G.
        The influence of cortisone on experimental fungus infections in mice.
        J. Clin. Invest. 1960; 39: 1435
        • Gresham G.A.
        • Burns M.
        Tissue invasion by Candida.
        in: Progress in Biological Science in Relation to Dermatology. Cambridge University Press, London1960: 174
        • Masshoff W.
        • Adam W.
        Histomorphologie der experimentellen, Candida-Infektion.
        Arch. klin. Exper. Dermat. 1957; 204: 416
        • Adriano S.M.
        • Schwartz J.
        Experimental moniliasis in mice.
        Am. J. Path. 1955; 31: 859
        • Donomae I.
        • Tsubura E.
        • Kuroda M.
        • Takahashi H.
        Experimental studies on treatment of candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 122
        • Winner H.I.
        Experimental moniliasis in the guinea-pig.
        J. Path. & Bact. 1960; 79: 420
        • Hazen E.L.
        • Brown R.
        • Mason A.
        Protective action of fungicidin (nystatin) in mice against virulence enhancing activity of oxytetracycline on Candida albicans.
        Antibiotics & Chemother. 1953; 3: 1125
        • Dukes C.D.
        • Tettenbaum I.S.
        Studies on the potentiation of monilial and staphylococcal infections by tetracycline.
        Antibiotics Ann. 1954–1955; : 674
        • Roth Jr., F.J.
        • Eylar O.R.
        A selective enhancement by Aureomycin of the pathogenicity of Candida albicans for mice.
        in: Bact. Proc.1954: 87
        • DeMello G.C.
        • Kiser J.S.
        The effect of several chemical compounds on experimental infections with Candida albicans.
        Antibiotics Ann. 1954–1955; : 678
        • Pinkerton M.E.
        • Patterson M.
        The effect of some selected antibiotics on experimental candidiasis.
        Texas Rep. Biol. & Med. 1957; 15: 50
        • Winter Jr., W.D.
        • Foley G.E.
        Enhancement of Candida infection; differential distribution of renal lesions in mice treated with Aureomycin.
        J. Infect. Dis. 1956; 98: 150
        • Henry B.
        • Fahlberg W.J.
        The potentiating effect of hydrocortisone acetate and tetracycline on monilial infection in mice.
        Antibiotics & Chemother. 1960; 10: 114
        • Blue M.L.
        Generalized moniliasis following prolonged antimicrobial therapy.
        Sinai Hosp. J. 1960; 9: 65
        • Brown Jr., C.
        • Propp S.
        • Guest C.M.
        • Beebe R.T.
        • Early L.
        Fatal fungus infections complicating antibiotic therapy.
        J.A.M.A. 1953; 152: 206
        • Connett M.C.
        Fatal septic thrombophlebitis due to Candida albicans after prolonged antibiotic therapy.
        Arch. Surg. 1960; 81: 726
        • Richart R.
        • Dammin G.J.
        Candida tropicalis as a pathogen for man.
        New England J. Med. 1960; 263: 474
        • Ballowitz Von L.
        • Schafer H.
        Das Auftreten von Mykosen bei antibiotischer Behandlung im Kindesalter.
        Monatsschr. Kinderh. 1954; 102: 336
        • Broz O.
        • Kopriva K.
        A case of moniliasis in an infant with rare affection of the heart and pleura.
        Pediatrics. 1953; 8: 211
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94 (Cited in [58].): 234
        • Hradcova L.
        Thrush enterocolitis of premature infants as a complication of antibiotic treatment.
        Pediatricke listy. 1954; 9: 345
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94 (Cited in [58].): 234
        • Schmorl G.
        Ein Fall von Soormetastase in der Niere.
        Zentralbl: Bakt. 1890; 7: 329
        • Dobias B.
        Moniliasis in pediatrics.
        Am. J. Dis. Child. 1957; 94 (Cited in [58].): 234
        • Miyake M.
        • Okudaira M.
        Recently observed five autopsy cases of Candidiasis especially with references to our statistical and immuno-pathological investigations.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 35
        • Bendel Jr., W.L.
        • Race G.J.
        Acute disseminated Candidiasis in aplastic anemia.
        Arch. Int. Med. 1961; 108: 916
        • Chapman M.G.
        Fatal disseminated moniliasis during prolonged antibiotic therapy.
        California Med. 1957; 86: 120
        • Robertson J.A.
        Systemic moniliasis. Report of a case.
        California Med. 1956; 84: 115
        • Shurtleff D.B.
        • Peterson W.
        • Sherris J.C.
        Systemic Candida tropicalis infection treated with amphotericin.
        New England J. Med. 1963; 269: 1112
        • Barrett B.
        • Volwiler W.
        • Kirby W.M.M.
        • Jensen C.R.
        Fatal systemic moniliasis following pancreatitis.
        Arch. Int. Med. 1957; 99: 209
        • Boyd J.F.
        • Chappell A.G.
        Fatal mycetosis due to Candida albicans after combined steroid and antibiotic therapy.
        Lancet. 1961; 2: 19
        • French G.
        • Shenoi V.
        Disseminated moniliasis with demonstration of the organism in the blood.
        Canad. M. A. J. 1954; 71: 238
        • Schaberg A.
        • Hildes J.A.
        • Wilt J.C.
        Disseminated candidiasis.
        Arch. Int. Med. 1955; 95: 112
        • Skobel P.
        • Jorke D.
        • Schabenski G.
        Akute generalisierte Mykose: Sepsis durch Candida pseudotropicalis.
        München med. Wchnschr. 1955; 97: 194
        • Louria D.B.
        • Stiff D.P.
        • Bennett B.
        Disseminated moniliasis in the adult.
        Medicine. 1962; 41 (Cited in [165].): 307
        • Higuchi K.
        • Iwasaki H.
        Systemic candidiasis complicated with leukaemia.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 176
        • Yaffe S.A.
        Superinfection and systemic moniliasis.
        Canad. M. A. J. 1958; 78: 944
        • Rankin N.E.
        Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy.
        Brit. M. J. 1953; 1: 918
        • Merchant R.K.
        • Louria D.B.
        • Geisler P.H.
        • Edgcomb J.H.
        • Utz J.P.
        Fungal endocarditis: review of the literature and report of three cases.
        Ann. Int. Med. 1958; 48: 242
        • Pearl M.A.
        • Sidransky H.
        Candida endocarditis. Two new cases, with a review of twelve cases previously reported.
        Am. Heart J. 1960; 6: 345
        • Koelle W.A.
        • Pastor B.H.
        Candida albicans endocarditis after aortic valvulotomy.
        New England J. Med. 1956; 255: 997
        • Persellin R.H.
        • Haring O.M.
        • Lewis F.J.
        Fungal endocarditis following cardiac surgery.
        Ann. Int. Med. 1961; 54: 127
        • Sanger P.W.
        • Taylor F.H.
        • Robicsek F.
        • Germuth F.
        • Senterfit L.
        • McKinnon G.
        Candida infection as a complication of heart surgery.
        J.A.M.A. 1962; 181: 88
        • Utz J.P.
        • Roberts W.C.
        Candida endocarditis: an emerging peril in cardiovascular surgery.
        Ann. Int. Med. 1961; 54: 1058
        • Evans W.E.D.
        • Winner H.I.
        The histogenesis of the lesions in experimental moniliasis in rabbits.
        J. Path. & Bact. 1954; 67: 531
        • Hurley R.
        • Winner H.I.
        The pathogenicity of Candida tropicalis.
        J. Path. & Bact. 1962; 84: 33
        • Diaz J.J.
        Moniliasis urinaria tras la terapeutica con antibioticos.
        Rev. clin. espãn. 1953; 48: 97
        • Davis J.B.
        • Whitaker J.D.
        • Ding L.K.
        • Kiefer J.H.
        Disseminated, fatal, post-partum candidiasis with renal suppuration: case report.
        J. Urol. 1956; 75: 930
        • Goldman H.J.
        • Littman M.L.
        • Oppenheimer G.D.
        • Glickman S.I.
        Monilial cystitis—effective treatment with instillations of amphotericin B.
        J.A.M.A. 1960; 174: 359
        • Albers D.D.
        Monilial infection of the kidney: case reports.
        J. Urol. 1953; 69: 32
        • Gillam J.F.E.
        • Wadelton D.H.
        A case of renal moniliasis.
        Brit. M. J. 1958; 1: 985
      264. Editorial. Moniliasis in the urinary tract.
        J.A.M.A. 1960; 174: 405
        • Engelhard C.F.
        Candida albicans infection in a child.
        J. Pediat. 1948; 32: 404
        • Guze L.B.
        • Haley L.D.
        Fungus infections of the urinary tract.
        Yale J. Biol. & Med. 1958; 30: 292
        • Stenderup A.
        • Pedersen G.T.
        Yeasts of human origin.
        Acta path. et microbiol. scandinav. 1962; 54: 462
        • Beckmann A.J.
        • Navarro J.E.
        Pneumonia complicating oral thrush treated with mycostatin, a new antifungal antibiotic.
        J. Pediat. 1955; 46: 587
        • Findlay Jr., C.W.
        • Kleinfeld G.
        Monilial empyema treated successfully with intrapleural instillations of amphotericin B.
        J. Thoracic & Cardiooasc. Surg. 1959; 38: 244
        • McKendrick G.D.W.
        • Medlock J.M.
        Pulmonary moniliasis treated with nystatin aerosol.
        Lancet. 1958; 1: 621
        • Mukherjee B.B.
        Bronchopulrnonary moniliasis.
        J. Indian M. A. 1958; 31: 363
        • Osimani J.J.
        Un caso de moniliasis bronquial tratado con nistatin.
        An. Fac. med. Montevideo. 1956; 41: 309
        • Paquette J.P.
        Mycose pulmonaire et infection pulmonaire à staphylocoques pyogènes.
        Union med. Canada. 1960; 89: 1164
        • Romano A.
        • Casuccio L.
        • Martinez R.
        Azione della nistatina somministrata per via aerosolica in soggetti portatori di Candida A. nell'albero bronchiale.
        Boll. Soc. ital. biol. sper. 1958; 34: 923
        • Sahni P.S.
        Pulmonary moniliasis.
        J. Pediat. 1957; 50: 484
        • Viola M.S.
        • Roda A.P.
        Bronchopulrnonary moniliasis with a case report.
        J. Philippine M.A. 1956; 32: 347
        • Kurotchkin T.J.
        • Lim C.E.
        Experimental bronchomoniliasis in sensitized rabbits.
        in: Proc. Soc. Exper. Biol. & Med.31. 1933: 332
        • Urso B.
        Nuovo contributo alla bronchomoniliasi sperimental.
        Arch. ital. sc. med. trop. 1950; 31: 77
        • Aoyama S.
        • Ata S.
        Studies on candidiasis.
        in: Studies on Candidiasis in Japan. Research Committee of Candidiasis, Education Ministry, Japan1961: 115-121
        • Felisati D.
        • Bastianini L.
        • De Mitri T.
        Antibiotics and Candida albicans given by endobronchial route.
        Antibiotics & Chemother. 1959; 9: 744
        • Castellani A.
        Reports.
        Ceylon M. Rep. 1904–1914;
        • Winner H.I.
        • Hurley R.
        Candida Albicans.
        J. & A. Churchill Ltd, London W.11964 (Cited in [10].)
        • Haley L.D.
        • McCabe A.
        A mycologic study of seventy-one autopsies.
        Am. J. Clin. Path. 1950; 20: 35
        • Bratlund H.
        • Holten C.
        Moniliasis of the mucous membranes and lungs as a complication of treatment with antibiotics corticotropin arid cortisone.
        Danish M. Bull. 1954; 1: 79
        • Shrewsbury J.F.D.
        Secondary thrush of the bronchi.
        Quart. J. Med. 1936; 5: 375
        • Riddell R.W.
        • Clayton Y.M.
        Pulmonary mycoses occurring in Britain.
        Brit. J. Tubers. 1958; 52: 34
        • Charpin J.
        • Zafiropoulo A.
        • Blanc M.
        Allergies respiratoires dués à Candida albicans.
        Path. et Biol. 1960; 8: 319
        • Keeney E.L.
        Candida asthma.
        Ann. Int. Med. 1951; 34: 223
        • Keeney E.L.
        Pulmonary mycotic infections. Allergic and immunologic factors.
        California Med. 1954; 81: 367
        • Neufeld O.
        • Wallbank W.L.
        Case of Candida asthma and its management.
        J. Michigan M. Soc. 1952; 51: 1419
        • Oblath R.W.
        • Donath D.H.
        • Kerr W.J.
        Pulmonary moniliasis.
        Ann. Int. Med. 1951; 35: 97
        • Scott P.W.
        A possible case of pulmonary moniliasis.
        Am. Rev. Tuberc. 1958; 77: 329
        • Goldin M.
        • Libretti A.
        • Hoffman A.
        • Kaplan M.A.
        Studies on antibodies to yeasts in bronchial asthma.
        Ann. Allergy. 1957; 15: 119
        • Angioli G.
        • Gorecki Z.
        Combined use of nystatin and antituberculous drugs in the management of coexistent fungaltuberculous infections.
        Canad. M. A. J. 1960; 82: 1274
        • Rioux J.-A.
        • Verdier P.
        • Plane J.
        Sur la fréquence des infestations saprophytiques à Candida chez les tuberculeux pulmonaires.
        Le Poumon. 1954; 10: 101
        • Schulte H.W.
        Die lokalisierte Candidamykose in Kombination mit der Lungentuberkulose.
        Tuberkulosearzt. 1957; 11: 751
        • Schwarting V.M.
        • Skinner C.E.
        Candida in sputum of patients with tuberculosis.
        Mycopathologia (The Haag). 1949; 4: 349
        • Seuderling Y.
        • Kumlin T.
        Some aspects of pulmonary mycosis.
        Ann. med. int. Fenniae. 1951; 40: 295
        • Falkmer S.
        • Wising P.J.
        Fatal bronchopulmonary moniliasis.
        Acta med. scandinav. 1955; 151: 117
        • Floch H.
        “Moniliase” broncho-pulmonaire en Guyane française.
        Bull. Soc. path. Exot. 1952; 45: 620
        • Florange W.
        Soorpneumonie als Folge massiver Antibioticatherapie.
        Med. Klin. 1954; 49: 225
        • Smith G.M.
        • Armen R.N.
        Pulmonary moniliasis treated by brilliant green aerosol: report of a case.
        Ann. Int. Med. 1955; 43: 1302
        • Hurwitz A.
        • Yesner R.
        A report of a case of localized bronchopulmonary moniliasis successfully treated by surgery.
        J. Thoracic Surg. 1948; 17: 826
        • Rey J.C.
        • Natin I.
        Moniliasis pulmonar.
        Prensa méd. argent. 1953; 40: 2306
        • Smulewicz J.
        Über einen Fall von Moniliasis der Lungen.
        Schweiz. med. Wchnschr. 1953; 83: 702
        • Vadala A.J.
        Mycotic infection of bronchopulmonary tract.
        Ann. Otol. Rhin. & Laryng. 1940; 49: 291
        • Kostmann R.
        Moniliasis of the respiratory tract.
        Acta paediat. 1945; 32 (Cited in [9].): 520
        • Keiper T.W.
        Studies on yeastlike fungi isolated from pulmonary disease (bronchoraoniliasis).
        J. Lab. & Clin. Med. 1938; 23: 343
        • Kostmann R.
        Moniliasis of the respiratory tract.
        Acta paediat. 1945; 32 (Cited in [9].): 520
        • Browne S.G.
        Moniliasis following antibiotic therapy.
        Lancet. 1954; 1: 393
        • Pace L.
        Un caso di moniliasi settica con rara complicazione pneumonica.
        Riform. Medica. 1957; 71: 36
        • Sivertson S.E.
        • Jaeck J.L.
        Hypersensitivity angiitis of the lung. Report of a case associated with pulmonary moniliasis.
        Wisconsin M. J. 1960; 59: 197
        • Steinberg I.
        Fatal fungus infection in sarcoidosis: report of two cases treated with antibiotics and cortisone.
        Ann. Int. Med. 1958; 48: 1359
        • Wilson J.W.
        Therapy of systemic fungous infections in 1961.
        Arch. Int. Med. 1961; 108: 292
        • Sarewitz A.B.
        Treatment of genitourinary moniliasis with orally administered nystatin.
        Ann. Int. Med. 1955; 42: 1187
        • Kozinn P.J.
        • Taschdjian C.L.
        • Dragutsky D.
        • Minsky A.
        Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B.
        Antibiotics Ann. 1956–1957; : 128
        • Solomon P.
        Oral moniliasis complicating combined-broad-spectrum-antibiotic and antifungal therapy.
        New England J. Med. 1961; 265: 847
        • Chamberlain C.
        • Burros H.M.
        • Borromeo V.
        Tetracycline and tetracycline-nystatirt in chronic urinary tract infections.
        Antibiotic Med. 1958; 5: 521
        • Gallaraga E.
        • Williams M.D.
        • Billow B.W.
        The clinical trial of tetracycline phosphate complex combined with nystatin in the treatment of bacterial pneumonia.
        Antibiotics Ann. 1957–1958; : 439
        • Gimble A.I.
        • Shea J.G.
        • Katz S.
        Nystatin and tetracycline in the treatment of bacterial infections.
        Antibiotics Ann. 1955–1956; : 676
        • Takahashi H.
        • Tsubura E.
        • Tanaka H.
        • Hirao F.
        Effect of oral administration of inystatin (mycostatin) and tetracycline-nystatin (Mysteclin) tablets.
        J. Antibiotics. 1958; 11 (s. A. supp.:): 30
        • Welch H.
        A rational approach to combined antibiotic therapy.
        Antibiotic Med. & Clin. Therapy. 1956; 3: 375
        • Welch H.
        The place of nystatin in chemotherapy.
        Antibiotic Med. 1956; 2: 79

      Article Info

      Publication History

      Received: July 21, 1965

      Identification

      DOI: https://doi.org/10.1016/0002-9343(66)90204-X

      Copyright

      © 1966 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX